Intranasal treatment of ferrets with inert bacterial spores reduces disease caused by a challenging h7n9 avian influenza virus

HIGHLIGHTS

• who: Joe James and colleagues from the Animal and Plant Health Agency (APHA), Woodham Lane, Weybridge , NB, Surrey, UK Department of Biological Sciences, Royal Holloway University of, Egham , EX, Surrey, UK have published the research work: Intranasal Treatment of Ferrets with Inert Bacterial Spores Reduces Disease Caused by a Challenging H7N9 Avian Influenza Virus, in the Journal: Vaccines 2022, 1559 of /2022/
• what: The authors investigate the protective efficacy of inert B. subtilis spores in the ferret model of influenza infection, using the H7N9 subtype for challenge. The authors show that intranasal applications of inert . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.